LifeStance Health Group, Inc. Amortization of Intangible Assets
LifeStance Health Group, Inc. (LFST) reported Amortization of Intangible Assets of $2.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- LifeStance Health Group, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $2.94M, a 12.68% decline year-over-year.
- LifeStance Health Group, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $2.95M, a 14.83% decline year-over-year.
- LifeStance Health Group, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $3.09M, a 32.18% decline year-over-year.
- LifeStance Health Group, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $3.21M, a 31.73% decline year-over-year.
- LifeStance Health Group, Inc. amortization of intangible assets for fiscal 2025 was $13.13M, a 56.61% decline from fiscal 2024.
- LifeStance Health Group, Inc. amortization of intangible assets for fiscal 2024 was $30.27M, a 29.70% decline from fiscal 2023.
- LifeStance Health Group, Inc. amortization of intangible assets for fiscal 2023 was $43.06M, a 6.91% increase from fiscal 2022.
- LifeStance Health Group, Inc. amortization of intangible assets for fiscal 2022 was $40.28M, a 3.17% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 1 month | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 4 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.94M 10-Q · filed 2026-08-06 | $5.89M 10-Q · filed 2026-08-06 | $8.98M derived: sum of 3 quarters · filed 2026-08-06 | $12.19M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $2.95M 10-Q · filed 2026-05-07 | $6.04M derived: sum of 2 quarters · filed 2026-05-07 | $9.25M derived: sum of 3 quarters · filed 2026-05-07 | $12.62M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.30M derived: sum of 2 quarters · filed 2026-02-25 | $9.67M derived: sum of 3 quarters · filed 2026-08-06 | $13.13M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $3.21M 10-Q · filed 2025-11-06 | $6.58M derived: sum of 2 quarters · filed 2026-08-06 | $10.05M 10-Q · filed 2025-11-06 | $14.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $3.37M 10-Q · filed 2026-08-06 | $6.83M 10-Q · filed 2026-08-06 | $11.39M derived: sum of 3 quarters · filed 2026-08-06 | $16.09M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $3.47M 10-Q · filed 2026-05-07 | $8.02M derived: sum of 2 quarters · filed 2026-05-07 | $12.72M derived: sum of 3 quarters · filed 2026-05-07 | $21.20M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.26M derived: sum of 2 quarters · filed 2026-02-25 | $17.73M derived: sum of 3 quarters · filed 2026-02-25 | $30.27M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $4.71M 10-Q · filed 2025-11-06 | $13.18M derived: sum of 2 quarters · filed 2025-11-06 | $25.72M 10-Q · filed 2025-11-06 | $38.26M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $8.47M 10-Q · filed 2025-08-07 | $21.01M 10-Q · filed 2025-08-07 | $33.56M derived: sum of 3 quarters · filed 2026-02-25 | $43.73M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $12.54M 10-Q · filed 2025-05-07 | $25.09M derived: sum of 2 quarters · filed 2026-02-25 | $35.26M derived: sum of 3 quarters · filed 2026-02-25 | $45.44M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $12.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $22.72M derived: sum of 2 quarters · filed 2026-02-25 | $32.89M derived: sum of 3 quarters · filed 2026-02-25 | $43.06M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $10.17M 10-Q · filed 2024-11-07 | $20.35M derived: sum of 2 quarters · filed 2024-11-07 | $30.52M 10-Q · filed 2024-11-07 | $40.65M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $10.18M 10-Q · filed 2024-08-08 | $20.35M 10-Q · filed 2024-08-08 | $30.48M derived: sum of 3 quarters · filed 2025-02-27 | $40.68M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $10.17M 10-Q · filed 2024-05-09 | $20.30M derived: sum of 2 quarters · filed 2025-02-27 | $30.50M derived: sum of 3 quarters · filed 2025-02-27 | $40.50M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $20.33M derived: sum of 2 quarters · filed 2025-02-27 | $30.32M derived: sum of 3 quarters · filed 2025-02-27 | $40.28M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $10.20M 10-Q · filed 2023-11-08 | $20.20M derived: sum of 2 quarters · filed 2023-11-08 | $30.15M 10-Q · filed 2023-11-08 | $40.06M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $9.99M 10-Q · filed 2023-08-09 | $19.95M 10-Q · filed 2023-08-09 | $29.86M derived: sum of 3 quarters · filed 2024-02-28 | $39.67M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $9.96M 10-Q · filed 2023-05-10 | $19.86M derived: sum of 2 quarters · filed 2024-02-28 | $29.68M derived: sum of 3 quarters · filed 2024-02-28 | $39.38M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $19.72M derived: sum of 2 quarters · filed 2024-02-28 | $29.42M derived: sum of 3 quarters · filed 2024-02-28 | $39.04M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $9.81M 10-Q · filed 2022-11-09 | $19.52M derived: sum of 2 quarters · filed 2022-11-09 | $29.14M 10-Q · filed 2022-11-09 | $38.48M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $9.70M 10-Q · filed 2022-08-10 | $19.32M 10-Q · filed 2022-08-10 | $28.66M derived: sum of 3 quarters · filed 2023-03-09 | $37.92M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $9.62M 10-Q · filed 2022-05-11 | $18.96M derived: sum of 2 quarters · filed 2023-03-09 | $28.22M derived: sum of 3 quarters · filed 2023-03-09 | $32.89M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $9.34M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $18.60M derived: sum of 2 quarters · filed 2023-03-09 | $23.27M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $9.26M 10-Q · filed 2021-11-10 | $13.93M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $4.67M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $503.00K 10-Q · filed 2021-08-12 | $1.44M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $3.06M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |